Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

Related Articles by Review for PubMed (Select 19602051)

1.

PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's disease.

Morel M, Couturier J, Lafay-Chebassier C, Paccalin M, Page G.

J Cell Mol Med. 2009 Aug;13(8A):1476-88. doi: 10.1111/j.1582-4934.2009.00849.x. Epub 2009 Jul 7. Review.

PMID:
19602051
2.

The dsRNA protein kinase PKR: virus and cell control.

García MA, Meurs EF, Esteban M.

Biochimie. 2007 Jun-Jul;89(6-7):799-811. Epub 2007 Mar 12. Review.

PMID:
17451862
3.

Regulation of protein synthesis by insulin.

Proud CG.

Biochem Soc Trans. 2006 Apr;34(Pt 2):213-6. Review.

PMID:
16545079
4.

Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.

Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribé E, Dalfó E, Avila J.

Curr Alzheimer Res. 2005 Jan;2(1):3-18. Review.

PMID:
15977985
5.

PKR; a sentinel kinase for cellular stress.

Williams BR.

Oncogene. 1999 Nov 1;18(45):6112-20. Review.

6.

Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.

Imahori K, Uchida T.

J Biochem. 1997 Feb;121(2):179-88. Review.

7.

Regulation of translation initiation by amino acids in eukaryotic cells.

Kimball SR.

Prog Mol Subcell Biol. 2001;26:155-84. Review.

PMID:
11575165
8.

PKR activation in neurodegenerative disease.

Peel AL.

J Neuropathol Exp Neurol. 2004 Feb;63(2):97-105. Review.

PMID:
14989595
9.

Glycogen synthase kinase 3beta and Alzheimer's disease: pathophysiological and therapeutic significance.

Balaraman Y, Limaye AR, Levey AI, Srinivasan S.

Cell Mol Life Sci. 2006 Jun;63(11):1226-35. Review.

PMID:
16568235
10.

mTOR-dependent signalling in Alzheimer's disease.

Pei JJ, Hugon J.

J Cell Mol Med. 2008 Dec;12(6B):2525-32. doi: 10.1111/j.1582-4934.2008.00509.x. Review.

PMID:
19210753
11.

The regulation of the protein kinase PKR by RNA.

Robertson HD, Mathews MB.

Biochimie. 1996;78(11-12):909-14. Review.

PMID:
9150867
12.

PERK and PKR: old kinases learn new tricks.

Raven JF, Koromilas AE.

Cell Cycle. 2008 May 1;7(9):1146-50. Epub 2008 Feb 21. Review.

13.

Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.

Hampel H, Shen Y.

Scand J Clin Lab Invest. 2009;69(1):8-12. doi: 10.1080/00365510701864610. Review.

PMID:
18609117
14.

Protein kinase C as a peripheral biomarker for Alzheimer's disease.

de Barry J, Liégeois CM, Janoshazi A.

Exp Gerontol. 2010 Jan;45(1):64-9. doi: 10.1016/j.exger.2009.10.015. Epub 2009 Nov 4. Review.

PMID:
19895879
15.

Roles of eIF2α kinases in the pathogenesis of Alzheimer's disease.

Ohno M.

Front Mol Neurosci. 2014 Apr 16;7:22. doi: 10.3389/fnmol.2014.00022. eCollection 2014. Review.

16.

Signaling pathway cross talk in Alzheimer's disease.

Godoy JA, Rios JA, Zolezzi JM, Braidy N, Inestrosa NC.

Cell Commun Signal. 2014 Mar 28;12:23. doi: 10.1186/1478-811X-12-23. Review.

17.

Autophagy modulation for Alzheimer's disease therapy.

Zhu XC, Yu JT, Jiang T, Tan L.

Mol Neurobiol. 2013 Dec;48(3):702-14. doi: 10.1007/s12035-013-8457-z. Epub 2013 Apr 27. Review.

PMID:
23625314
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk